Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

STK16

RBC: STK16 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Abemaciclib94.60.56
Gilteritinib90.20.51
Defactinib85.20.45
Palbociclib78.10.67
Pacritinib75.50.45
Midostaurin61.30.50
Fostamatinib59.50.61
Fedratinib50.60.58
Sunitinib47.40.52
Pazopanib41.60.67
Ponatinib33.10.53
Nintedanib31.80.61
Pralsetinib27.30.64
Avapritinib27.20.64
Alectinib25.60.65

Known variants

No variants catalogued.
Open in new tab